Synopsis of recent research by authors named "Sae Takashima"
- Sae Takashima’s recent research focuses on the predictive role of diffuse positivity of TTF-1 expression in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) undergoing treatment with platinum-doublet chemotherapy and immune checkpoint inhibitors.
- The study retrospectively analyzed data from 74 patients with TTF-1-positive recurrent or advanced NSCLC, aiming to clarify the association between TTF-1 expression and treatment efficacy.
- Findings indicate that understanding the extent of TTF-1 positivity could provide valuable insights into tailoring treatment strategies for improved outcomes in this patient population.
